Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, updating the page's version label. This change updates the page's version indicator without altering substantive content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA footer “Revision” label was updated from v3.5.2 to v3.5.3, indicating a minor site or build version change rather than an update to the clinical study record.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3. No user-visible changes to the study information or layout.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision tag updated to v3.4.2. The previous Revision: v3.4.1 tag has been removed.SummaryDifference0.1%

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.